Current perspectives on systemic therapy for metastatic non-clear cell renal cell carcinoma
The improvements in the knowledge of the underlying biology of renal cell carcinoma (RCC) has led to consider this disease as a group of different entities characterized by their pathological phenotype, and the particular features exhibited in their microenvironment. Non-clear cell RCC (nccRCC) repr...
Main Authors: | J. González, G. Ciancio |
---|---|
Format: | Article |
Language: | English |
Published: |
Verduci Editore
2020-12-01
|
Series: | CellR4 |
Subjects: | |
Online Access: | https://www.cellr4.org/wp-content/uploads/sites/2/2020/12/e2988.pdf |
Similar Items
-
The role of sunitinib in the therapy of metastatic renal cell carcinoma
by: I. G. Rusakov, et al.
Published: (2020-07-01) -
The Continuing Question of Adjuvant Therapy in Clear Cell Renal Cell Carcinoma
by: Stephanie A. Berg, et al.
Published: (2022-12-01) -
Large Renal Cell Carcinoma with Multiple Metastases Presenting as Low Back Pain
by: Yu-Yin Lin, et al.
Published: (2014-06-01) -
Tyrosine Kinase Inhibitors in the Treatment of Metastasised Renal Cell Carcinoma—Future or the Past?
by: Jakob Michaelis, et al.
Published: (2022-08-01) -
First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?
by: Yann-Alexandre Vano, et al.
Published: (2021-11-01)